Limes Schlosskliniken Forecast, price target & analysts
Limes Schlosskliniken Target price 2026 - Analyst rating & recommendation
Limes Schlosskliniken Classifications & Recommendation
Limes Schlosskliniken Price Target
| Target Price | €711.45 |
| Price | €530.00 |
| Potential |
34.24%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Limes Schlosskliniken 2027 .
The average Limes Schlosskliniken target price is €711.45.
This is
34.24%
register free of charge
€850.50
60.47%
register free of charge
€590.85
11.48%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend Limes Schlosskliniken to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Limes Schlosskliniken stock has an average upside potential 2027 of
34.24%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 53.95 | 65.30 |
| 41.53% | 21.03% | |
| EBITDA Margin | 23.71% | 24.59% |
| 28.19% | 3.72% | |
| Net Margin | 10.57% | 12.76% |
| 29.50% | 20.77% |
3 Analysts have issued a sales forecast Limes Schlosskliniken 2026 . The average Limes Schlosskliniken sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Limes Schlosskliniken EBITDA forecast 2026. The average Limes Schlosskliniken EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Limes Schlosskliniken Analysts have issued a net profit forecast 2026. The average Limes Schlosskliniken net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 19.11 | 27.78 |
| 80.11% | 45.37% | |
| P/E | 18.72 | |
| EV/Sales | 2.53 |
3 Analysts have issued a Limes Schlosskliniken forecast for earnings per share. The average Limes Schlosskliniken EPS is
This results in the following potential growth metrics and future valuations:
Limes Schlosskliniken...
Current Limes Schlosskliniken Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| NUWAYS AG |
Locked
➜
Locked
|
Locked | Sep 01 2026 |
| NUWAYS AG |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| NUWAYS AG |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Apr 07 2026 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Apr 06 2026 |
| NUWAYS AG |
Locked
➜
Locked
|
Locked | Feb 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
NUWAYS AG:
Locked
➜
Locked
|
Sep 01 2026 |
|
Locked
NUWAYS AG:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
NUWAYS AG:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Apr 07 2026 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Apr 06 2026 |
|
Locked
NUWAYS AG:
Locked
➜
Locked
|
Feb 05 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
